Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Cardiac autonomic testing and treating heart disease. "A clinical perspective".

DePace NL Sr, Mears JP, Yayac M, Colombo J.

Heart Int. 2014 Nov 19;9(2):45-52. doi: 10.5301/heartint.5000216. Review.

2.

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.

BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19. Review.

3.

Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

Scarpioni R, Ricardi M, Albertazzi V, Melfa L.

World J Nephrol. 2012 Dec 6;1(6):184-94. doi: 10.5527/wjn.v1.i6.184. Review.

4.

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF.

Ann Intern Med. 2012 Aug 21;157(4):263-75. doi: 10.7326/0003-4819-157-4-201208210-00007. Review.

5.

The complex interplay between cholesterol and prostate malignancy.

Solomon KR, Freeman MR.

Urol Clin North Am. 2011 Aug;38(3):243-59. doi: 10.1016/j.ucl.2011.04.001. Review.

6.

Renal failure (chronic).

Clase C.

BMJ Clin Evid. 2011 May 25;2011. pii: 2004. Review.

7.

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis.

März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C; German Diabetes and Dialysis Study Investigators..

Clin J Am Soc Nephrol. 2011 Jun;6(6):1316-25. doi: 10.2215/CJN.09121010.

8.

Benefits of statin therapy and compliance in high risk cardiovascular patients.

Lardizabal JA, Deedwania PC.

Vasc Health Risk Manag. 2010 Oct 5;6:843-53. doi: 10.2147/VHRM.S9474. Review.

9.

Renal lipid metabolism and lipotoxicity.

Bobulescu IA.

Curr Opin Nephrol Hypertens. 2010 Jul;19(4):393-402. doi: 10.1097/MNH.0b013e32833aa4ac. Review.

10.

Kidney function and estimated vascular risk in patients with primary dyslipidemia.

Tziomalos K, Ganotakis ES, Gazi IF, Nair DR, Mikhailidis DP.

Open Cardiovasc Med J. 2009 Jun 16;3:57-68. doi: 10.2174/1874192400903010057.

Items per page

Supplemental Content

Support Center